This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2005 Jan 1;62(1):83-7.

doi: 10.1093/ajhp/62.1.83.

Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia

Dawn Marie Stull¹, Robyn Bilmes, Helen Kim, Rick Fichtl

Affiliations

PMID: 15658078
DOI: 10.1093/ajhp/62.1.83

Clinical Trial

Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia

Dawn Marie Stull et al. Am J Health Syst Pharm. 2005.

. 2005 Jan 1;62(1):83-7.

doi: 10.1093/ajhp/62.1.83.

Authors

Dawn Marie Stull¹, Robyn Bilmes, Helen Kim, Rick Fichtl

Affiliation

¹ Department of Pharmacy, New York Presbyterian Hospital-New York Weill Cornell Center, New York, NY 10128, USA. dmstull@nyp.org

PMID: 15658078
DOI: 10.1093/ajhp/62.1.83

No abstract available

PubMed Disclaimer

Similar articles

Myeloid growth factors.
Crawford J, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J, Freifeld AG, Goemann M, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, Michaud LB, Miyata SC, Tallman MS, Vadhan-Raj S, Westervelt P, Wong MK; National Comprehensive Cancer Network. Crawford J, et al. J Natl Compr Canc Netw. 2009 Jan;7(1):64-83. doi: 10.6004/jnccn.2009.0006. J Natl Compr Canc Netw. 2009. PMID: 19176207 No abstract available.
Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy.
Weycker D, Malin J, Barron R, Edelsberg J, Kartashov A, Oster G. Weycker D, et al. Am J Clin Oncol. 2012 Jun;35(3):267-74. doi: 10.1097/COC.0b013e31820dc075. Am J Clin Oncol. 2012. PMID: 21378538
Formulary management of colony-stimulating factors.
Whalen CR, Watson TL, Baize T, Ball A. Whalen CR, et al. Am J Health Syst Pharm. 2002 Apr 1;59(7 Suppl 2):S21-7. doi: 10.1093/ajhp/59.suppl_2.S21. Am J Health Syst Pharm. 2002. PMID: 11944611
Clinical applications of colony-stimulating factors: a historical perspective.
Sylvester RK. Sylvester RK. Am J Health Syst Pharm. 2002 Apr 1;59(7 Suppl 2):S6-12. doi: 10.1093/ajhp/59.suppl_2.S6. Am J Health Syst Pharm. 2002. PMID: 11944613 Review.
Comparative safety of filgrastim versus sargramostim in patients receiving myelosuppressive chemotherapy.
Milkovich G, Moleski RJ, Reitan JF, Dunning DM, Gibson GA, Paivanas TA, Wyant S, Jacobs RJ. Milkovich G, et al. Pharmacotherapy. 2000 Dec;20(12):1432-40. doi: 10.1592/phco.20.19.1432.34861. Pharmacotherapy. 2000. PMID: 11130215

See all similar articles

Cited by

Utilization of G-CSF and GM-CSF as an alternative to discontinuation in clozapine-induced neutropenia or leukopenia: A case report and discussion.
Karst A, Lister J. Karst A, et al. Ment Health Clin. 2018 Aug 30;8(5):250-255. doi: 10.9740/mhc.2018.09.250. eCollection 2018 Sep. Ment Health Clin. 2018. PMID: 30206510 Free PMC article.
Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure.
Singh VK, Seed TM. Singh VK, et al. Front Pharmacol. 2021 May 10;12:624844. doi: 10.3389/fphar.2021.624844. eCollection 2021. Front Pharmacol. 2021. PMID: 34040517 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems